# Zarminali Health

Startup profile on Capital Atlas: https://capitalatlas.ai/startups/zarminali-health

- Industry: Healthcare Specialists
- Headquarters: Chicago, US
- Website: www.zarminali.com
- Total disclosed funding: $81M
- Latest round: Series A (Jan 21, 2026)
- Investors on record: 3

## About

Based in Illinois, US, and founded in 2024 by CEO Danish Qureshi, Zarminali Health, Inc., a.k.a. Zarminali operates as a provider of specialized practice management support services for outpatient pediatric physician practices. In January 2026, Zarminali Health, Inc. raised USD 110 million in series A funding led by new investor Healthier Capital, with participation from another new investor K2 HealthVentures. Returning investor General Catalyst Partners also participated in the round.

Zarminali Health specializes in providing comprehensive practice management support services tailored for outpatient pediatric physician practices. The company has developed an integrated care model designed to streamline healthcare delivery, making it accessible for families navigating pediatric care. The firm’s offerings encompass a range of solutions, including care coordination tools, technology integration, and administrative support for pediatric clinicians. The core clientele encompasses pediatric patients and their families, as well as pediatric clinicians.

Zarminali Health's revenue model primarily revolves around partnerships with outpatient pediatric practices, where they provide integrated support services essential for enhancing operational efficiency and patient care. The transactions typically occur on a business-to-business (B2B) basis, where pediatric practices engage Zarminali for ongoing practice management solutions. These partnerships facilitate a structure that encompasses subscription-based services, ensuring steady revenue flow through continuous support and technology integration.

The company plans to utilize the January 2026 funding to expand its platform, enter new markets, open clinics, and grow into urgent and specialty care.

## Funding rounds

- Series A, Jan 21, 2026, $55M — General Catalyst Partners, K2 HealthVentures, Healthier Capital
- Seed, Nov 20, 2024, $26M — General Catalyst Partners

## Investors

- General Catalyst Partners (https://capitalatlas.ai/funds/general-catalyst-partners) — Seed, Series A
- K2 HealthVentures (https://capitalatlas.ai/funds/k2-healthventures) — Series A
- Healthier Capital (https://capitalatlas.ai/funds/healthier-capital) — Series A